In last trading session, Pfizer Inc. (NYSE:PFE) saw 60.92 million shares changing hands with its beta currently measuring 0.65. Company’s recent per share price level of $27.70 trading at $0.52 or 1.91% at ring of the bell on the day assigns it a market valuation of $156.42B. That closing price of PFE’s stock is at a discount of -45.74% from its 52-week high price of $40.37 and is indicating a premium of 9.03% from its 52-week low price of $25.20. Taking a look at company’s average trading volume volume of 41.19 million if we extend that period to 3-months.
Pfizer Inc. (NYSE:PFE) trade information
Upright in the green during last session for gaining 1.91%, in the last five days PFE remained trading in the green while hitting it’s week-highest on Thursday, 05/02/24 when the stock touched $27.70 price level, adding 0.86% to its value on the day. Pfizer Inc.’s shares saw a change of -3.79% in year-to-date performance and have moved 9.66% in past 5-day. Pfizer Inc. (NYSE:PFE) showed a performance of 1.76% in past 30-days.
Pfizer Inc. (PFE) estimates and forecasts
Statistics highlight that Pfizer Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -9.36% of value to its shares in past 6 months, showing an annual growth rate of 22.28% while that of industry is 4.40. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 2.60% from the last financial year’s standing.
13 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 13.08B for the same. And 13 analysts are in estimates of company making revenue of 15B in the next quarter. Company posted 12.73B and 13.23B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -27.43% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 24.48% while estimates for its earnings growth in next 5 years are of -1.33%.
PFE Dividends
Pfizer Inc. is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
